Pfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut

by | Jul 25, 2022 | Uncategorized

Despite Paxlovid’s efficacy in reducing the risks for high-risk patients, uptake has been lower than expected. Read More